MoneyWorks4Me

Orchid Pharma informs about analyst meet

15 Dec 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it enclosed the schedule of Analyst / Institutional Investor Meetings. Copy of the presentation is also available on Company’s official website: www.orchidpharma.com. The schedule may undergo change due to unforeseen exigencies on the part of Investors/ Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.55
Dr. Reddys Labs. 1142.10
Cipla 1355.20
Lupin 2043.20
Zydus Lifesciences 1097.20
View more..